Meeting
2020 Genitourinary Cancers Symposium
Replacing TURBT with mpMRI for staging MIBC: Pilot data from the BladderPath study.
Authors
Nicholas D. James
Queen Elizabeth Hospital, Birmingham, United Kingdom
Nicholas D. James , Sarah Pirrie , Wenyu Liu , Rashid Amir , Jean Gallagher , Ana Hughes , Kieran Jefferson , Allen Knight , Veronica Nanton , Harriet Paige Mintz , Ann Pope , James WF Catto , Prashant Patel , Richard T. Bryan
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers
Track
Urothelial Carcinoma,Adrenal Cancer,Penile Cancer,Prostate Cancer - Advanced,Prostate Cancer - Localized,Testicular Cancer,Urethral Cancer
Sub Track
Imaging
Clinical Trial Registration Number
35296862
Citation
J Clin Oncol 38, 2020 (suppl 6; abstr 446)
Abstract #
446
Poster Bd #
F13
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
Identification of muscle-invasion status in bladder cancer patients using natural language processing and machine learning.
First Author: Ruixin Yang
Poster
2023 ASCO Genitourinary Cancers Symposium
Response Evaluation Criteria in Tumors of the Bladder (RECIT-Bladder) for future window of opportunity trials as a platform to accelerate drug development.
First Author: Christopher Gaffney
Poster
2022 ASCO Genitourinary Cancers Symposium
Safety and efficacy of neoadjuvant intravesical oncolytic MV-NIS in patients with urothelial carcinoma.
First Author: Shruthi Naik
Poster
2020 ASCO Virtual Scientific Program
Clinical outcomes and economic burden for bladder cancer patients: An analysis from a Swedish cancer registry.
First Author: Joaquim Bellmunt